ArticleExperimental and therapeutic medicine2024

Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation.

Linfeng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.